La chaîne d'options affiche les données clés des options sur actions de Mega Matrix à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Mega Matrix..

Mega Matrix (AMEX:MPU) Stock, Chaîne d'Options

Mega Matrix

Mega Matrix Inc formerly Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment.

Mega Matrix Inc

WIIM

QBTS

D-Wave Quantum shares are trading higher on continued strength after the company on Thursday reported a 502% year-over-year increase in Q4 bookings to $18.3 million.

WideOpenWest shares are trading higher following Q4 financial results.

GOGO

Gogo shares are trading higher after the company reported better-than-expected Q4 financial results.

PTON

Peloton Interactive shares are trading higher after Canaccord Genuity upgraded the stock from Hold to Buy.

CANG

Cango shares are trading higher after the company received a preliminary non-binding letter of intent from Enduring Wealth Capital Limited.

XPOF

Xponential Fitness shares are trading lower after the company reported Q4 financial results.

SMTC

Semtech shares are trading higher after the company reported better-than-expected Q4 financial results.

AAOI

Applied Optoelectronics shares are trading higher after the company announced a warrant issuance agreement transaction with Amazon for 7,945,399 shares.

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth maintains IN8bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INAB#NASDAQ">INAB</a>) with a Buy and lowers the price target from $8 to $6.

News

Price Target

Analyst Ratings

INAB

HC Wainwright & Co. Maintains Buy on IN8bio, Lowers Price Target to $6

Polyrizon Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today that it has signed a non-binding Letter of Intent (LOI) with a biotech company focused on psychedelic-derived therapeutics ("the psychedelic company"), to develop a novel intranasal formulation for psychedelic-based treatment applications.
This agreement aims to leverage Polyrizon's proprietary platform to optimize the delivery of innovative psychedelic treatments for therapeutic use. This collaboration emphasizes the growing potential of intranasal drug delivery in the psychedelic medicine space, offering an innovative approach to enhancing bioavailability, efficacy, and patient accessibility. If successful, this collaboration has the potential to pave the way for further clinical development and commercialization.

Biotech

General

PLRZ

Polyrizon Signs Non– Binding LOI With A Biotech Company Focused On Psychedelic-derived Therapeutics, To Develop A Novel Intranasal Formulation For Psychedelic-Based Treatment Applications

AMIX

Autonomix Medical Completes Integration And Design Enhancements Of Apex 6 Generator

Science Applications International Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIC#NASDAQ">SAIC</a>) will release its fourth-quarter financial results, before <a href="https://www.benzinga.com/quote/SAIC/earnings">the opening bell, on Monday, March 17.</a>
Analysts expect the company to report quarterly earnings at $2.09 per share, up from $1.43 per share in the year-ago period. Science Applications International projects quarterly revenue of $1.81 billion, compared to $1.74 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
With the recent buzz around SAIC, some investors may be eyeing potential gains from the company's dividends too. As of now, SAIC offers an annual dividend yield of 1.42%, which is a quarterly dividend amount of 37 cents per share ($1.48 a year). &nbsp;
So, how can investors exploit its dividend yield to pocket a regular $500 monthly?
To earn $500 per month or $6,000 annually from dividends alone, you would need an investment of approximately $422,670 or around 4,054 shares. For a more modest $100 per month or $1,200 per year, you would need $84,555 or around 811 shares.
To calculate: Divide the desired annual income ($6,000 or $1,200) by the dividend ($1.48 in this case). So, $6,000 / $1.48 = 4,054 ($500 per month), and $1,200 / $1.48 = 811 shares ($100 per month).
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
How that works: The dividend yield is computed by dividing the annual dividend payment by the stock&#8217;s current price.
For example, if a stock pays an annual dividend of $2 and is priced at $50, the dividend yield would be 4% ($2/$50). However, if the stock price increases to $60, the dividend yield drops to 3.33% ($2/$60). Conversely, if the stock price falls to $40, the dividend yield rises to 5% ($2/$40).
Similarly, changes in the dividend payment can impact the yield. If a company increases its dividend, the yield will also increase, provided the stock price stays the same. Conversely, if the dividend payment decreases, so will the yield.
SAIC Price Action: Shares of Science Applications International fell 0.4% to close at $104.26 on Thursday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44298504/top-3-health-care-stocks-youll-regret-missing-this-quarter">Top 3 Health Care Stocks You&#8217;ll Regret Missing This Quarter</a></li>
</ul>
Photo: Shutterstock

Earnings

Long Ideas

Markets

Trading Ideas

SAIC

How To Earn $500 A Month From Science Applications International Stock Ahead Of Q4 Earnings

Helport AI Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HPAI#NASDAQ">HPAI</a>) ("Helport AI" or the "Company"), an AI technology company serving enterprise clients with intelligent customer communication software, services, and solutions, today announced that Mr. Tao Ke is no longer serving as Chief Financial Officer ("CFO") of the Company, effective March 12, 2025. The Company has appointed Amy Fong, President and Director of Helport AI, as interim CFO, effective immediately.
"We take this opportunity to thank Tao for his contributions in assisting Helport AI in its transition into a public company this past year and wish him the best in his future endeavors," said Guanghai Li, Chief Executive Officer of Helport AI. "We believe that Amy's extensive financial and operational leadership experience, coupled with her deep understanding of capital markets, makes her well-positioned to oversee our finance functions, as we search for a permanent replacement for this role."
Ms. Fong, who was appointed President and Director of Helport AI in January 2025, brings over 25 years of experience as a seasoned professional across multiple industries, including banking, private equity, management consulting, and the not-for-profit sector. Prior to joining Helport AI, she was the Chief Operating Officer and later Managing Director of Sustainability and Strategic Initiatives at FountainVest Partners (Asia) since 2019, before transitioning to the role of Senior Advisor in 2024. She previously served as the Chief Executive Officer of Save the Children Hong Kong, a non-governmental organization, and spent two decades in financial services with JP Morgan, Credit Suisse, and Merrill Lynch in both the U.S. and Asia. She holds an MBA degree in Finance from Columbia Business School and a BSBA degree in Accounting and International Finance from Georgetown University.
"I look forward to working closely with our talented teams and supporting the identification of a suitable candidate to serve as our permanent Chief Financial Officer," said Amy Fong. "We believe that Helport AI is at an exciting inflection point, and we remain focused on accelerating growth and delivering value to our customers and shareholders."

Management

HPAI

Helport AI Limited Appoints Amy Fong As Interim CFO, Effective Immediately.

Block, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>) shares are trading higher in the premarket session on Friday.
On Thursday, the company announced that Square Financial Services, Inc, its industrial bank, has received approval from the Federal Deposit Insurance Corporation to offer the Cash App Borrow<a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/b44315699/square-financial-services-inc-receives-fdic-approval-to-offer-consumer-loan-product-cash-app-borro" rel="noreferrer noopener"> consumer loan product.</a>
This approval enables SFS, an independently governed subsidiary of Block, to provide small, short-term loans to Cash App users, driving further economic empowerment.
Cash App Borrow, which has seen significant adoption with nearly $9 billion in originations in 2024, offers loans averaging less than $100 with a one-month duration.
These loans are designed to offer an affordable alternative to high-cost payday loans and overdraft fees.
Also Read:<a target="_blank" href="https://www.benzinga.com/25/02/43919256/block-square-cash-app-poised-for-2h-weighted-profit-growth-says-bullish-analyst" rel="noreferrer noopener"> Block&#8217;s Square, Cash App Poised For 2H-Weighted Profit Growth: Analyst</a>
The product maintains historically low loss rate of under 3%, with the majority of revenue coming from on-time paying customers.
As part of a gradual rollout, SFS will begin servicing and originating Cash App Borrow loans in the coming weeks, continuing to support both businesses and consumers with transparent and accessible financial solutions.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, XYZ stock has lost over 33% in the past year. Investors can gain exposure to the stock via VanEck Digital Transformation ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAPP#NASDAQ">DAPP</a>).
Recently, the company was in the headlines for being the first company in North America to deploy&nbsp;NVIDIA's&nbsp;DGX SuperPOD <a target="_blank" href="https://www.benzinga.com/25/03/44286204/whats-going-on-with-block-stock-on-wednesday" rel="noreferrer noopener">with DGX GB200 systems.</a>
This deployment by Block, set for an Equinix data center, will be utilized to advance research and training in open-source generative AI models, focusing on novel solutions for underexplored areas.
This move follows Block's launch of&nbsp;codename goose, an open-source AI agent framework, and signals the company's continued commitment to AI-driven innovation.
Price Action: XYZ shares are trading higher by 2.63% to $55.46 premarket at last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44320221/chuck-schumer-says-a-government-shutdown-will-give-trump-the-keys-to-the-city-state-and-country-and-elon-musk-the-chance-to-destroy-government-services" target="_blank" rel="noreferrer noopener">Chuck Schumer Says A Government Shutdown Will Give Trump The &#8216;Keys To The City, State and Country&#8217; And Elon Musk The Chance To Destroy Government Services</a></li>
</ul>
Image via Shutterstock.

Equities

Movers

DAPP

What's Going On With Block Stock On Friday?

HC Wainwright &amp; Co. analyst Andrew Fein maintains Vigil Neuroscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIGL#NASDAQ">VIGL</a>) with a Buy and lowers the price target from $17 to $14.

VIGL

HC Wainwright & Co. Maintains Buy on Vigil Neuroscience, Lowers Price Target to $14

DOCU

DocuSign shares are trading higher following better-than-expected Q4 financial results.

New Update Overhauls Groups Layout, Improves Security
SARASOTA, Fla., March 14, 2025 (GLOBE NEWSWIRE) -- Trump Media and Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) ("TMTG" or the "Company"), operator of the social media platform Truth Social, the streaming platform Truth+, and the FinTech brand Truth.Fi, released an update to the Truth Social app today to enhance the "Groups" feature.
The layout for Groups—which allows users to join together and share content related to specific themes, hobbies, or interests—has been overhauled and improved, including with the addition of an explorer feed. The update makes it easier to discover new Groups and Groups content, and arranges for more dynamic content to be served to Groups users. It also improves control for Groups administrators while implementing new measures for bot mitigation and other security enhancements.

Trump Media And Technology Group Updates Truth Social With Overhauled Groups Layout, Explorer Feed, And Enhanced Security

Hepion Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hepa#NASDAQ">HEPA</a>), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic steatohepatitis ("NASH"), hepatocellular carcinoma ("HCC"), and other chronic
Hepion Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEPA#NASDAQ">HEPA</a>), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic steatohepatitis ("NASH"), hepatocellular carcinoma ("HCC"), and other chronic liver diseases, today announced that it will implement a 1-for-50 reverse split of the issued shares of its common stock, effective at 4:01 p.m. Eastern Time on March 17, 2025. The Company's common stock is expected to begin trading on a split-adjusted basis when the market opens on March 18, 2025, and will continue to trade on The Nasdaq Capital Market under the symbol "HEPA." The new CUSIP number for the common stock will be 426897 401.
The reverse stock split is intended to increase the bid price of the common stock to enable the Company to regain compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market. The Company's stockholders authorized the reverse stock split at the Company's annual meeting of stockholders held on March 10, 2025.

Penny Stocks

Stock Split

HEPA

Hepion Pharmaceuticals Announces 1-For-50 Reverse Stock Split Effective March 17, 2025

RBRK

Rubrik shares are trading higher after the company reported better-than-expected Q4 financial results and issued Q1 guidance above estimates.

The DEPEND study demonstrates that checkpoint inhibitor nivolumab (Opdivo&#xAE;) works best with high levels of PD-L1 biomarker, but does not work well with low levels of PD-L1
Multikine&#x2A; is uniquely positioned in the field as the only oncology drug used as a neoadjuvant that has demonstrated overall survival benefit in head and neck cancer patients whose tumors express low levels of PD-L1
Multikine aims to address a major treatment gap for head and neck cancer patients where about 70% have low PD-L1 expression, in its upcoming confirmatory Registration Trial
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcel-sci.com%2F&amp;esheet=54223970&amp;newsitemid=20250314970798&amp;lan=en-US&amp;anchor=CEL-SCI+Corporation&amp;index=1&amp;md5=0ce157001ccda3a5a8e3d1caba8cd8a9">CEL-SCI Corporation</a> (NYSE:<a href="https://www.benzinga.com/stock/CVM#NYSE">CVM</a>) today announced that a third-party study published on March 6, 2025 in JAMA Oncology titled "Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Non-randomized Clinical Trial" provided data that support Multikine's use as a neoadjuvant treatment in patients with tumors having low PD-L1 expression in its upcoming confirmatory head and neck cancer Registration Trial.

CEL-SCI Announces That A Third-Party Study Published In Jama Oncology Titled "Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-stratified Chemoradiation Therapy In HPV-Negative Head And Neck Cancer: The DEPEND Phase 2 Non-Randomized Clinical Trial" Provided Data That Support Multikine's Use As A Neoadjuvant Treatment In Patients With Tumors Having Low PD-L1

Entertainment

Small Cap

Press Releases

Mega Matrix Inc. Attended China-UAE Industry and Investment Cooperation Conference to Further Deepen Middle East Short Drama Strategy

Mega Matrix Inc. Announced that Romantic Drama Micro-drama "Runaway Billionaire Becomes My Groom" Now Streaming on FlexTV

Mega Matrix Inc. Announced that Romantic Comedy "From Rags to Riches Pet Shop Cinderella" Now Streaming on FlexTV

Mega Matrix Inc. Announced that FlexTV and Telkomsel Launch the FlexTV Premium Bundling Package, Offering Affordable Vertical Short Drama Content in Indonesia

Mega Matrix Inc. Announced that the Tragic Romance Series "After All These Years" Premiered on FlexTV

Mega Matrix Inc. Announced that the Urban Romance Micro Drama "A flash Marriage With The Billionaire Tycoon" Premiered on FlexTV

Mega Matrix Inc. Announced that the Royal Comeback Drama "From Lost Heiress to Royal Highness" Now Streaming on FlexTV

MPU FlexTV Awarded "TOP 10 National Micro-Short Drama Overseas Platforms" at the 14th China International New Media Short Film Festival, Co-hosted by the National Radio and Television Administration

Mega Matrix Inc. Announced Seven New English Short Dramas on FlexTV (March 3-7): Rebirth, Suspense & Passionate Romance

Mega Matrix Inc. and 9 Yards Cinema Production established JV ahead of $100M 'Short Drama Investment Fund' launch

Anghami

BloomZ

Brera Holdings PLC - Class B Ordinary Shares

Brera Holdings

Cineverse

Pop Culture Group Co., Ltd - Class A Ordinary Shares

Pop Culture Gr

CuriosityStream Inc. - Class A Common Stock

CuriosityStream

Dolphin Entertainment, Inc. - Common Stock

Dolphin Entertainment

Gaia

Global Mofy AI Limited - Class A Ordinary Shares

Global Mofy AI

Kuke Music Holding Limited American Depositary Shares (each representing ten (10) Class A Ordinary Shares)

Kuke Music Hldg

LiveOne

Lytus Technologies Holdings PTV. Ltd. - Common Shares

Lytus Technologies Hldgs

Moving iMage Technologies, Inc. Common Stock

Moving iMage Technologies

NIP Group Inc. - American Depositary Shares

NIP Group

PodcastOne

Reading International Inc - Class A Non-voting Common Stock

Reading Intl

Reading International Inc - Class B Voting Common Stock

Scienjoy Holding Corporation - Class A Ordinary Shares

Scienjoy Holding

Sound Group Inc. - American Depositary Shares

Comments

Mega Matrix

Mega Matrix (MPU) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL